AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Microbot Medical Inc. Director's Dealing 2010

May 19, 2010

33819_dirs_2010-05-19_e4e8f8e1-97dc-4bbb-909b-4bb56ebcd18f.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: STEMCELLS INC (STEM)
CIK: 0000883975
Period of Report: 2010-05-15

Reporting Person: TSUKAMOTO ANN (EVP, Research and Development)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2010-05-15	Common Stock	F	12058	$1.09	Disposed	186683	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	22834	Indirect
Common Stock	44596	Indirect

Footnotes

F1: Includes (1) 70,000 restricted stock units, with 23,333 vesting on each of May 15, 2011, May 15, 2012 and May 15, 2013 and (2) 68,750 restricted stock units, vesting on March 10, 2011.

F2: 22,834 shares held in trust as to which Dr. Tsukamoto disclaims beneficial ownership.

F3: Shares held in 401(k) account, in accordance with issuer's employer-match policies.